Tevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 6,937 shares, an increase of 190.6% from the May 14th total of 2,387 shares. Based on an average daily volume of 113,822 shares, the short-interest ratio is currently 0.1 days.
Tevogen Bio Stock Performance
NASDAQ:TVGNW traded down $0.00 during trading hours on Friday, reaching $0.05. 5,137 shares of the company were exchanged, compared to its average volume of 134,497. Tevogen Bio has a 52-week low of $0.03 and a 52-week high of $0.08. The stock has a 50 day simple moving average of $0.04 and a 200 day simple moving average of $0.04.
Tevogen Bio Company Profile
Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.
The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.
Featured Stories
- Five stocks we like better than Tevogen Bio
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
